Genpath Pharmaceuticals Inc - 02139 Cambridge, MA

Business Name: Genpath Pharmaceuticals Inc
Categorized In:
Address: 300 Technology Square # 7, Cambridge, MA 02139
Phone Number: (516) 417-5500
Contact Person: Amy Monighetti
NAICS Code: 325412
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 2007
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Infinity Pharmaceuticals Inc - Cambridge, MA 02139
Novartis Corporation - Cambridge, MA 02139
Millennium Pharmaceuticals - Cambridge, MA 02139
Cerulean Pharma Inc - Cambridge, MA 02139
Kedrion Biopharma Inc - Cambridge, MA 02139
R A Pharmaceuticals - Cambridge, MA 02139
Johnson & Johnson - Cambridge, MA 02139
Alnara Pharmaceuticals Inc - Cambridge, MA 02139
Agios Pharmaceuticals Inc - Cambridge, MA 02139
Novartis Vaccines & Dgnstcs - Cambridge, MA 02139
Sirtris Pharmaceuticals Inc - Cambridge, MA 02139
Novartis Vaccines And Diagnostics Inc - Cambridge, MA 02139
Intellikine LLC - Cambridge, MA 02139
Genzyme Corporation - Cambridge, MA 02139
Idenix Pharmaceuticals Inc - Cambridge, MA 02139
Aveo Pharmaceuticals Inc - Cambridge, MA 02139
Novirio Pharmaceuticals Inc - Cambridge, MA 02139
Idm Pharma Inc - Cambridge, MA 02139
Tbk Pharmaceuticals Inc - Cambridge, MA 02139
Vertex Pharmaceuticals Inc - Cambridge, MA 02139

Genpath Pharmaceuticals Inc provides professional from its single location at the coordinates 42.362961,-71.091511.

The company offers BOTH variables under the SIC code 2834 and NAICS code 325412, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 2007, the company can now be visited at 300 Technology Square # 7, Cambridge, Massachusetts 02139 or contacted through representative Amy Monighetti at (516) 417-5500.

For frequently asked questions and further inquiries about professional , get to know more about Genpath Pharmaceuticals Inc through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.